Diadia
Our TechnologyResourcesAboutLoginBook a call

© 2026 Diadia. All rights reserved.

About UsOur TechnologyResearchResources
Privacy Policy
SupportBook a callLogin
Health Privacy Policy
InstagramFacebookLinkedInX (formerly Twitter)
Terms and Conditions
About UsOur TechnologyResearchResources
Privacy Policy
SupportBook a callLogin
Health Privacy Policy
InstagramFacebookLinkedInX (formerly Twitter)
Terms and Conditions

© 2026 Diadia. All rights reserved.

←Transparency Reports

endocrine · Mechanism Report

Does low LH with low testosterone indicate central hypogonadism?

Low LH with low testosterone indicates central hypogonadism.

PlausibleJuly 8, 202615 Sources

Reasoning Paths

Each route from condition to outcome carries a support score — the product of its edge weights. Select one to isolate it on the figure.

This is what AI claimed

low luteinizing hormone with low testosterone indicates central hypogonadism due to inadequate pituitary stimulation of Leydig cell testosterone production

laying out figure…
1 of 4 paths supported
UnsupportedPlausibleSupported

How to read the figure

Evidence state

  • ●EstablishedStrong, replicated evidence.
  • ◐ModerateEvidence-informed; limited or moderate.
  • ◇PlausibleMechanistically coherent, not established.
  • ✕UnsupportedTested and not supported — link breaks.
  • ?MissingNo evidence either way — untested.

Node shapes

  • BiomarkerA measurable state — a lab value, hormone, or genetic factor.
  • ProcessA biological process, pathway, or mechanism step.
  • ConditionA condition, exposure, intervention, or symptom.
  • OutcomeThe endpoint the claim leads to.

Executive summary

The claim says that when testosterone is low and LH is low or inappropriately normal, the pattern points to a central cause rather than primary testicular failure. The mechanism framing is that insufficient pituitary LH signaling reduces Leydig cell steroidogenesis, including the StAR-dependent steps needed for testosterone production.

Verified conclusion

The regulation of testosterone synthesis depends on a highly coordinated feedback loop within the hypothalamic-pituitary-testicular axis.

Clinical diagnostic criteria

  • Biochemical profile: Central (secondary) hypogonadism is clinically defined by the coexistence of consistently low testosterone levels and low or inappropriately normal luteinizing hormone (LH) levels.
  • Diagnostic standards: Guidelines from the Endocrine Society and the American Urological Association (AUA) require confirming testosterone deficiency on at least two separate morning, fasting total testosterone measurements (typically defined as <300 ng/dL). Assessing LH levels then differentiates the etiology; elevated LH points to primary testicular failure, whereas low or inappropriately normal LH establishes a central etiology.

Molecular and mechanistic pathways

  • Intracellular signaling: Pituitary LH binds to LH receptors (LHCGR) on Leydig cells, activating a Gs-coupled adenylyl cyclase pathway that elevates intracellular cyclic adenosine monophosphate (cAMP) and activates protein kinase A (PKA).
  • Rate-limiting step: Activated PKA phosphorylates and upregulates the steroidogenic acute regulatory (StAR) protein, which facilitates the rate-limiting transport of cholesterol across mitochondrial membranes for conversion into testosterone via downstream enzymes like CYP11A1 and 3β-HSD.
  • Direction of causality: Inadequate pituitary LH secretion deprives Leydig cells of this stimulatory signal, downregulating cAMP-PKA-StAR signaling and causing Leydig cell atrophy. Crucially, primary Leydig cell failure does not cause central hypogonadism; instead, primary testicular failure removes negative feedback, leading to compensatory pituitary hypersecretion and elevated LH.

Bottom line

  • Low LH combined with low testosterone (<300 ng/dL) is diagnostic of central hypogonadism, reflecting a pituitary failure to stimulate Leydig cell cAMP-PKA-StAR signaling rather than primary testicular dysfunction.

References

  1. Male Hypogonadism | Choose the Right Test - ARUP Consult — arupconsult.com ↗
  2. Diagnosing and managing low serum testosterone - PMC — pmc.ncbi.nlm.nih.gov ↗
  3. Assessment and management of male androgen disorders: an update — racgp.org.au ↗
  4. Male Hypogonadism - Endocrinology - Merck Manuals — merckmanuals.com ↗
  5. Prevalence, Diagnosis and Treatment of Hypogonadism in Primary ... — bumc.bu.edu ↗
  6. Hypogonadism: Practice Essentials, Background, Pathophysiology — emedicine.medscape.com ↗
  7. A practical guide to male hypogonadism in the primary care setting — pmc.ncbi.nlm.nih.gov ↗
  8. Leydig cells: formation, function, and regulation - PMC - NIH — pmc.ncbi.nlm.nih.gov ↗
  9. Diagnosis of Male Central Hypogonadism During Childhood - PMC — pmc.ncbi.nlm.nih.gov ↗
  10. Steroidogenesis in Leydig Cells: Effects of Aging and Environmental ... — pmc.ncbi.nlm.nih.gov ↗
  11. Regulation of the steroidogenic acute regulatory protein gene ... - PMC — pmc.ncbi.nlm.nih.gov ↗
  12. Effect of Long Term Deprivation of Luteinizing Hormone on Leydig ... — academic.oup.com ↗
  13. Reversal of long-term LH deprivation on testosterone secretion and ... — pubmed.ncbi.nlm.nih.gov ↗
  14. Mechanism of Action of an Environmentally Relevant Organochlorine Mixture in Repressing Steroid Hormone Biosynthesis in Leydig Cells — pmc.ncbi.nlm.nih.gov ↗
  15. Steroidogenic Acute Regulatory Protein - ScienceDirect.com — sciencedirect.com ↗

See a full patient report verified like this

Book a walkthrough

Related Claims

Plausible8 sourcesCan obstructive sleep apnea lower testosterone in men?→Plausible5 sourcesDoes a non-elevated LH with low testosterone suggest secondary hypogonadism?→